PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsthrombocytopenic purpura
MeSH D011696 - thrombocytopenic purpura
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D011693:Purpura
4 Companies
1 Drug
$
Success rate
D057049:Thrombotic microangiopathies
0 Companies
0 Drugs
Success rate
D007154:Immune system diseases
2 Companies
2 Drugs
$
Success rate
D011696: 
Thrombocytopenic purpura
1 Company
1 Drug
$
Success rate
D011697:Thrombotic thrombocytopenic purpura
1 Company
1 Drug
$
Success rate
D016553:Thrombocytopenic purpura idiopathic
100 Companies
15 Drugs
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
27%
3/11
Phase 3
25%
1/4
Approved: 1Overall Success rate: 7%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Merck Sharp & Dohme
Interferon alfa-2b
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use